×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Simply Wall Street
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to...
6 days ago
Shareholders in Dermapharm Holding (ETR:DMP) are in the red if they invested three years ago
Yahoo Finance
Shareholders in Dermapharm Holding (ETR:DMP) are in the red if they invested three years ago ... In this article: DMPHF. Many investors define...
1 month ago
Dermapharm Holding Full Year 2023 Earnings: EPS: €1.16 (vs €2.49 in FY 2022)
Yahoo Finance
Key Financial Results · Revenue: €1.19b (up 15% from FY 2022). · Net income: €62.4m (down 54% from FY 2022). · Profit margin: 5.2% (down from 13...
1 month ago
Dermapharm Holding SE's (ETR:DMP) Price In Tune With Earnings
Simply Wall St
We've established that Dermapharm Holding maintains its high P/E on the strength of its forecast growth being higher than the wider market, as...
2 months ago
Canopy selling cannabinoid subsidiary C3 to German drugmaker Dermapharm
MJBizDaily
Pharmaceutical manufacturer Dermapharm Holding SE has struck a deal to buy C3 Cannabinoid Compound Co. GmbH from Canada's Canopy Growth.
28 months ago
Allergopharma - News | Merck
Merck KGaA
Merck today signed an agreement to sell its allergy business Allergopharma to Dermapharm Holding SE (“Dermapharm”).
50 months ago
Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company USA - English - USA - English
PR Newswire
PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) has entered into an agreement to divest...
28 months ago
Can Dermapharm Holding SE (ETR:DMP) Maintain Its Strong Returns?
Simply Wall Street
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany and...
1 month ago
WILHELM BEIER: The Visionary Behind Dermapharm's Success • Net Worth
SuperYachtFan
"Get an in-depth look into the life and achievements of Wilhelm Beier, founder of Dermapharm, a leading German pharmaceutical company.
38 months ago
Opinion: 2022 could be the year for pharmaceutical marijuana
MJBizDaily
Despite the success of adult-use marijuana, 2022 is looking like the year pharmaceutical cannabis becomes a major market driver.
25 months ago